IME reports 17% revenue growth, ARR $36.8m; EBITDA jumps 311%
ImExHS says revenue rose 17% year-over-year and ARR reached $36.8m. It also reports underlying EBITDA up 311% and guidance for FY26 calls for continued growth in revenue and earnings.
Revenue grew 17% year-over-year and ARR reached $36.8m, with radiology outperforming and software in line with expectations.
Underlying EBITDA surged 311% and guidance for FY26 anticipates continued growth in both revenue and earnings.Original document: ImExHS Ltd [IME] Slides Release — Sep.
2 2026…